Michael Camilleri, MD: Clinical Trials

3 completed. 3 Phase 2.

By phase and status

Phase	Trials	Status
Phase 2	3	Completed 3

Follow Michael Camilleri, MD: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
Aldafermin (NGM282) for Chronic Diarrhea Due to Bile Acid Malabsorption (BAM) Aldafermin, Placebo - Chronic Diarrhea, Irritable Bowel Syndrome With Diarrhea	Phase 2	Completed	Michael Camilleri, MD	30	2021-12-01	2023-10-12
Pilot Study of the Effect of Liraglutide 3.0 mg on Weight Loss and Gastric Functions in Obesity Liraglutide, Placebo - Obesity	Phase 2	Completed	Michael Camilleri, MD	136	2017-11-29	2022-06-23
Effect of Ileal Bile Acid Transporter Inhibitor in Functional Constipation A3309, placebo - Functional Constipation	Phase 2	Completed	Michael Camilleri, MD	36	2010-01-01	2020-09-04

Conditions studied

Obesity (1)

Interventions

Liraglutide (1)  ·  aldafermin (1)  ·  elobixibat (1)

Countries

United States (3)

Top investigators

Michael Camilleri, M.D. (1)

Results publications

PMID 21876564, PMID 26197999

NIH funding

R56DK067071 (1), UL1RR024150 (1), UL1TR000135 (1)